The deal between the U.S. and European Union on trade in pharmaceutical products promises to have a deep impact on the underlying structure of the industry.
President Donald Trump’s return to the White House in January kicked off a rollercoaster year for manufacturers, retailers and other U.S. industries dependent on goods from abroad.
Companies seeking to navigate uncertainties arising from the U.S-China trade relationship can take a proactive posture to enhance the competitiveness of domestic production.
American manufacturers rushing to bring production back home from Asia? Time for a reality check, according to the latest Reshoring Index from Kearney.
The latest supply-chain news, analysis, trends and tools for executives in the pharmaceutical and biotech industries. Learn how pharmaceutical and biotech companies and their suppliers around the world are managing the flow of products across all channels of the enterprise. Experts sound off on forecasting and demand planning, supply-chain visibility, logistics outsourcing, inventory optimization, transportation management, warehouse management, supply-chain security, corporate social responsibility and more.
Subscribe to our Daily Newsletter!
Timely, incisive articles delivered directly to your inbox.